Non-specialty pipeline forecast as of May 2009
This is a discussion on Non-specialty pipeline forecast as of May 2009 within the Non-Specialty Drug Pipeline by Month forum, part of the New Drug Approvals and Pipeline category; The following list represents non-specialty pipeline updates for May 2009 from DrugPipelineForecast . Please click on the product name to ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
06-02-2009, 01:06 PM
|
||||
|
||||
Non-specialty pipeline forecast as of May 2009
The following list represents non-specialty pipeline updates for May 2009 from DrugPipelineForecast. Please click on the product name to view update for individual products. To access DrugPipelineForecast, you must be a registered user of DrugManagementForum (click here to register)
Acetavance - NDA submitted Adcirca - FDA approved (removed from DrugPipelineForecast) Afresa - NDA accepted AVE 5530 and saredutant - programs cut by sanofi-aventis (removed from DrugPipelineForecast) Brilinta - positive Phase III results Bronchitol - positive Phase III results darusentan - positive Phase III results Daxas - submitted in EU Effient - post-hoc analysis results esomeprazole and aspirin - NDA submitted esomeprazole and naproxen - NDA to be filed 2Q09 ethinylestradiol and gestodene - Phase III trial initiated (new entry in DrugPipelineForecast) Fanapt - FDA approved (removed from DrugPipelineForecast) Feraheme - PDUFA date set Flutiform - NDA accepted fidaxomicin - positive Phase III results (new entry in DrugPipelineForecast) glycopyrronium - Phase III trial to start 6/09 (new entry in DrugPipelineForecast) glycopyrronium and indacaterol - Phase III trial to start 6/09 (new entry in DrugPipelineForecast) indacaterol - positive Phase III results ingenol mebutate - positive Phase III results (new entry in DrugPipelineForecast) Levadex - positive Phase III results (new entry in DrugPipelineForecast) lorcaserin - NDA filing by 4Q09 lurasidone - positive Phase III results (new entry in DrugPipelineForecast) mipomersen - positive Phase III results Multaq - positive Phase III results; FDA decision expected soon Nasalfent - submitted in EU pimavanserin - late Phase III (new entry in DrugPipelineForecast) Qutenza - approved in EU ruboxistaurin - positive Phase III results (new entry in DrugPipelineForecast) Staccato - positive Phase III results Stedesa - NDA submitted tapentadol - positive Phase III results (new entry in DrugPipelineForecast) telcagepant - NDA delayed tranexamic acid - NDA submitted Tyvaso – PDUFA date changed For more information, or to search additional drugs, please see DrugPipelineForecast Last edited by chantell.reagan : 06-02-2009 at 04:46 PM. 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Specialty pipeline forecast as of April 2009 | chantell.reagan | Specialty Drug Pipeline by Month | 0 | 05-05-2009 05:42 PM |
| Non-specialty pipeline forecast as of March 2009 | chantell.reagan | Non-Specialty Drug Pipeline by Month | 0 | 04-02-2009 05:20 PM |
| Specialty pipeline forecast as of March 2009 | chantell.reagan | Specialty Drug Pipeline by Month | 0 | 04-02-2009 05:19 PM |
| Non-specialty pipeline forecast as of February 2009 | chantell.reagan | Non-Specialty Drug Pipeline by Month | 0 | 03-05-2009 02:29 PM |
| Specialty pipeline forecast as of February 2009 | chantell.reagan | Specialty Drug Pipeline by Month | 0 | 03-05-2009 02:01 PM |
© 2008 DrugManagementForum™ powered by |
 |